Novo Nordisk Total Long-Term Assets 2010-2025 | NVO

Novo Nordisk total long-term assets for the quarter ending March 31, 2025 were $44.414B, a 67.14% increase year-over-year.

  • Novo Nordisk total long-term assets for 2024 were $44.21B, a 74.15% increase from 2023.
  • Novo Nordisk total long-term assets for 2023 were $25.387B, a 34.74% increase from 2022.
  • Novo Nordisk total long-term assets for 2022 were $18.842B, a 8.74% increase from 2021.

Novo Nordisk Total Long-Term Assets 2010-2025 | NVO

  • Novo Nordisk total long-term assets for 2024 were $44.21B, a 74.15% increase from 2023.
  • Novo Nordisk total long-term assets for 2023 were $25.387B, a 34.74% increase from 2022.
  • Novo Nordisk total long-term assets for 2022 were $18.842B, a 8.74% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$765.9B
Johnson & Johnson (JNJ)$400.3B
AbbVie (ABBV)$333B
Roche Holding AG (RHHBY)$258.9B
Novartis AG (NVS)$245.4B
Merck (MRK)$211.1B
Pfizer (PFE)$138.2B
Sanofi (SNY)$121.3B
Bayer (BAYRY)$32.8B
Innoviva (INVA)$1.2B